Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1985-4-8
pubmed:abstractText
The BALB/c IgA (immunoglobulin A) myeloma protein M167 contained on average 5.7 free SH groups per IgA dimer. These groups were preponderantly on the heavy chains and comprised two distinct populations: 3.3 exposed SH groups per dimer in the Fc region, and 2.4 buried SH groups per dimer in the Fd region, detectable o only after denaturation. To locate the cysteine residues involved, labelled peptides were purified from thermolysin digests of radioalkylated IgA by high-performance liquid chromatography. From the amino acid compositions of the peptides, the exposed thiol groups were assigned to Cys-307 in the C alpha 2 domain, which thus existed in the reduced form to an extent exceeding 80%. This residue may allow attachment of secretory component to dimer IgA in the mouse to proceed via thiol-disulphide exchange. The buried thiol groups were assigned to Cys-150 and Cys-208, in the C alpha 1 domain, each being in the reduced form to the extent of approx. 30%. This pair of residues would normally give rise to the characteristic intradomain disulphide bridge. It appears that disulphide formation is not a crucial event during folding of the C alpha 1 domain in IgA biosynthesis. The sequence in the region 140-151 was re-investigated, and residue 142 was shown to be serine, not cysteine, helping explain the lack of heavy-chain-light chain bonding in BALB/c mouse IgA. A disulphide-bond model for mouse IgA is proposed on the basis of these assignments and other features of the mouse alpha-chain sequence.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-1010601, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-1090614, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-1126937, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-118170, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-1253791, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-14082019, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-14189881, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-14216627, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-16749166, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-22018, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-286295, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-37780, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-393607, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-404358, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4112641, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4131279, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4169036, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4173394, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4566456, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-465472, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4675696, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4744337, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4812180, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-4998234, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-500111, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-5028497, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-5059886, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-5690602, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-5806584, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-5846989, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6196616, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6776528, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6786355, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6790349, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6790712, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6795191, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6801659, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6811754, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-6816276, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-7020376, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-7118396, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-7338898, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-7397107, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-7410374, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-7410848, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-804317, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-813765, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-821146, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-958465, http://linkedlifedata.com/resource/pubmed/commentcorrection/3977821-99160
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
225
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
113-25
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
The thiol groups of mouse immunoglobulin A. Incomplete formation of the C alpha 1-domain disulphide bridge.
More...